In vitro assays to predict the severity of hemolytic disease of the newborn (Q40934820)

25 September 2017

1 reference

title

In vitro assays to predict the severity of hemolytic disease of the newborn (English)

1 reference

25 September 2017

Hadley AG

1

1 reference

PubMed ID

8541713

25 September 2017

language of work or name

1 reference

1 October 1995

1 reference

Transfusion Medicine Reviews

25 September 2017

1 reference

25 September 2017

9

1 reference

25 September 2017

4

1 reference

25 September 2017

302-313

1 reference

Preventing Rh immunisation

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Production of additional atypical alloantibodies in Rh(D)-sensitized pregnancies managed by intrauterine investigation methods

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Maternal serum anti-D antibody concentration and assessment of rhesus isoimmunisation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

The prevention of Rh immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Reversal of Rh alloimmunization. Fact or fancy?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Anti-D Concentration in Mother and Child in Haemolytic Disease of the Newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Anti-D concentrations in fetal and maternal serum and amniotic fluid in rhesus allo-immunised pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Elevation of Cord over Maternal IgG Immunoglobulin: Evidence for an Active Placental IgG Transport

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Transplacental IgG subclass concentrations in pregnancies at risk of haemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Protection against Rh D-haemolytic disease of the newborn by a diminished transport of maternal IgG to the fetus

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Biology of Human Immunoglobulin G Fc Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Functional interactions of red cells sensitized by IgG1 and IgG3 human monoclonal anti-D with enzyme-modified human monocytes and FcR-bearing cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Allelic polymorphisms of human Fc gamma receptor IIA and Fc gamma receptor IIIB. Independent mechanisms for differences in human phagocyte function

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Blockade of clearance of immune complexes by an anti-Fc gamma receptor monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Anti-Rh(D) IgG subclasses and severity of Rh hemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Serological and immunological characteristics of maternal anti-Rh(D) antibodies in predicting the severity of haemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Immunoglobulin G subclasses and isoimmunized pregnancy outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

IgG subclasses and Gm allotypes of anti-D antibodies during pregnancy: correlation with the gravity of the fetal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Mononuclear phagocyte assays, autoanalyzer quantitation and IgG subclasses of maternal anti-RhD in the prediction of the severity of haemolytic disease in the fetus before 32 weeks gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

ADCC (K-cell) lysis of human erythrocytes sensitized with rhesus alloantibodies. III. Comparison of IgG anti-D agglutinating and lytic (ADCC) activity and the role of IgG subclasses

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Erythropoietic suppression in fetal anemia because of Kell alloimmunization

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Misleading results in the determination of haemolytic disease of the newborn using antibody titration and ADCC in a woman with anti-Lub

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Rhesus Du incompatibility in a newborn with high levels of anti D and a benign clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Maternal antibodies against fetal blood group antigens A or B: lytic activity of IgG subclasses in monocyte-driven cytotoxicity and correlation with ABO haemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Prenatal and perinatal immunohematology: recommendations for serologic management of the fetus, newborn infant, and obstetric patient

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

ADCC and other cellular bioassays for predicting the clinical significance of red cell alloantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Rh isoimmunization: a 24 year experience at Duke University Medical Center

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

The role of Rh antibodies in haemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Prediction of the severity of rhesus haemolytic disease of the newborn by an ADCC assay

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Prediction of the outcome of rhesus haemolytic disease of the newborn: additional information using an ADCC assay

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Bioassays to determine the clinical significance of red cell alloantibodies based on Fc receptor-induced destruction of red cells sensitized by IgG.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Monocyte monolayer assay: an efficient noninvasive technique for predicting the severity of hemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Monocyte monolayer assay, autoanalyser values, and haemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Predicting hemolytic disease of the newborn: a comparison of the monocyte monolayer assay and the chemiluminescence test

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Monocyte monolayer assay as a predictor of severity of hemolytic disease of the fetus and newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Prediction of the severity of haemolytic disease of the newborn. Quantitative IgG anti-D subclass determinations explain the correlation with functional assay results

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

The chemiluminescent response of human monocytes to red cells sensitized with monoclonal anti-Rh(D) antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Predicting the severity of rhesus alloimmunization: monocyte-mediated chemiluminescence versus maternal anti-D antibody estimation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR)

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Prenatal Determination of Fetal RhD Type by DNA Amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

Prenatal determination of fetal RhD type

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980078-1

7 January 2021

10.1016/S0887-7963(05)80078-1

Identifiers

DOI

1 reference

25 September 2017

1 reference

PubMed ID

8541713